Joint statement from the Society for Endocrinology and the British Thyroid Association regarding 'Association of Radioactive Iodine Treatment with cancer mortality in patients with hyperthyroidism'

Clin Endocrinol (Oxf). 2020 Mar;92(3):266-267. doi: 10.1111/cen.14136. Epub 2019 Dec 13.

Authors

Peter N Taylor¹, Onyebuchi E Okosieme^{1

2}, Krishna Chatterjee³, Kristien Boelaert⁴; Executive Committees of the Society for Endocrinology and the British Thyroid Association

Affiliations

¹ Thyroid Research Group, Systems Immunity Research Institute, Cardiff University School of Medicine, Cardiff, UK.
² Diabetes Department, Prince Charles Hospital, Cwm Taf Morgannwg University Health Board, Merthyr Tydfil, UK.
³ Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
⁴ Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.

PMID: 31788839
DOI: 10.1111/cen.14136

No abstract available

Publication types

Letter
Comment

MeSH terms

Endocrinology*
Humans
Hyperthyroidism*
Iodine Radioisotopes
Thyroid Neoplasms*

Substances

Iodine Radioisotopes